Navigation Links
Predictors Of Wound Infection In Ventral Hernia Repair

Abdominal wall hernias are one of the most common conditions treated by general surgeons, with more than 100,000 repairs// performed annually. Although ventral hernia repair (VHR) is a common operation, recurrences and complications remain a vexing problem. Wound infection has been identified as a consistent risk factor for recurrence after VHR.

A recent study, which appears in the November issue of The American Journal of Surgery was designed with the aim to identify predictors of postoperative wound infection in subjects undergoing VHR in a retrospective multicenter study of ventral hernia outcomes. The study examines patient- and procedure-specific variables associated with wound infection, and specifically focuses on the effect of mesh placement at VHR on postoperative wound complications.

For the study, a cohort of subjects undergoing VHR from 13 regional Veterans Health Administration (VHA) sites was identified. Patient-specific risk variables were obtained from National Surgical Quality Improvement Program (NSQIP) data. Operative variables were obtained from physician-abstracted operative notes. Univariate and multivariable logistic regression analysis was used to model predictors of postoperative wound infection.

A total of 1505 VHR cases were used for analysis; wound infection occurred in 5% (n = 74). Best-fit logistic regression models demonstrated that steroid use, smoking, prolonged operative time, and use of absorbable mesh, acting as a surrogate marker for a more complex procedure, were significant independent predictors of wound infection.

The results demonstrated that chronic steroid use, current smoking, prolonged operative time, and use of absorbable mesh (likely a marker for more complex intraoperative variables) were significant predictors of postoperative wound infection in VHR.

The only modifiable risk factor identified was current smoking. Smoking cessation prior to elective hernia repair may decrease the rate of wound infection and ultimately hernia recurrence. VHR remains a challenging problem for general surgeons. Mesh repair has been shown to decrease recurrence but is not systematically used. This study provides further evidence that use of permanent mesh prosthesis for VHR is not associated with increased wound complications in short-term follow-up. However, the authors state that long-term studies are needed to further verify the safety and efficacy of mesh use for ventral hernia repair.

About ventral hernia (Incisional Hernia):

A hernia is the protrusion of an organ through the wall that normally contains it. An incisional hernia occurs in the abdomen in the area of an old surgical scar. A part of an organ in the abdomen, such as the bowel or intestines, protrudes through the weakened area of the abdominal wall.
'"/>




Related medicine news :

1. Elevated LDL levels in Childhood could be Predictors of Heart Disease
2. Predictors for Type 2 Diabetes
3. Understanding The Predictors Of Prostate Cancer
4. Identifying Predictors Of Anthrax
5. Early Predictors Of Heart Disease
6. People With Genetic Predictors of Colorectal Cancer are Not Getting Screened
7. Wound healing made faster
8. Psychological Stress Delays Wound Healing
9. Wound healing affected by Psychological stress
10. Wound Healing Found To Be Slower In Couples Who Fight Often
11. ‘Marriage Squabbles’ bad for both Emotional and Physical Wound
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, ... with or without a referral. Dr. Cotey knows that interceptive orthodontics in ... When patients receive early treatment, they may achieve straight teeth with less treatment in ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical ... of the company’s executive management team with prominent executives from both inside and outside ... Chief Operating Officer, Ted Dumbauld , who has more than twenty years of ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... , ... March 29, 2017 , ... The Wharton School ... and Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates ...
(Date:3/28/2017)... Los Angeles, CA (PRWEB) , ... March 28, 2017 , ... ... “wake-up call” asking the American public to take the Diabetes Risk Test to find ... the event, the Los Angeles World Airports will light up the evening sky by ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017   Dynatronics Corporation (NASDAQ: ... of Cynthia L. McHenry (Cyndi) as ... for leading Dynatronics manufacturing, distribution, and purchasing operations ... Dynatronics, CEO Kelvyn H. Cullimore, Jr. ... search process conducted by the company as it ...
(Date:3/29/2017)... 29, 2017 On March 28, the U.S. Food and ... with relapsing forms of multiple sclerosis (MS) and primary ... approved by the FDA for PPMS. Ocrevus is an ... "Multiple sclerosis can have a profound impact ... M.D., director of the Division of Neurology Products in ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ... release financial results for the year ended December ... 26, 2017. The results are being released later ... financial statements will include the operations and balances ... 1, 2016.  This release and filing date meets ...
Breaking Medicine Technology: